Brief: Allovir Inc - Diana Brainard Steps Down As CEO Of Allovir
20/12/2024 21:50
Allovir Inc ALVR.O :
* ALLOVIR INC - DIANA BRAINARD STEPS DOWN AS CEO OF ALLOVIR
* ALLOVIR INC: APPOINTED VIKAS SINHA AS COMPANY'S CHIEF
EXECUTIVE
OFFICER AND "PRINCIPAL EXECUTIVE OFFICER
Source text: ID:n0001193125-24-283140
Further company coverage: ALVR.O
Recent news on Kalaris Therapeutics
See all newsKalaris Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Kalaris Therapeutics Q2 net loss narrows on lower administrative costs
Kalaris Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview
Kalaris Therapeutics posts smaller-than-expected Q1 net loss
Brief: Kalaris Therapeutics Inc Q1 Operating Income USD -11.833 Million